Imugene Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
-
1.20
1.70
2.70
Gross Income
-
-
1.20
1.70
2.70
SG&A Expense
1,291.40
2,884.60
4,267.70
3,683.20
5,775.20
EBIT
1,291.40
2,884.60
4,268.80
3,684.90
5,777.90
Unusual Expense
1,346.00
132.30
-
-
-
Non Operating Income/Expense
13.50
62.60
18.60
21.20
90.80
Pretax Income
2,623.70
3,041.10
4,248.00
3,670.60
5,774.40
Income Tax
507.70
600.30
1,517.40
1,164.00
1,840.80
Consolidated Net Income
2,116.00
2,440.80
2,730.60
2,506.60
3,933.60
Net Income
2,116.00
2,440.80
2,730.60
2,506.60
3,933.60
Net Income After Extraordinaries
2,116.00
2,440.80
2,730.60
2,506.60
3,933.60
Net Income Available to Common
2,116.00
2,440.80
2,730.60
2,506.60
3,933.60
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
Basic Shares Outstanding
695,408.00
1,187,098.50
1,332,676.10
2,087,698.80
2,637,869.80
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
695,408.00
1,187,098.50
1,332,676.10
2,087,698.80
2,637,869.80
EBITDA
1,291.40
-
4,267.70
3,683.20
5,775.30
Non-Operating Interest Income
27.10
38.40
39.40
35.40
94.30
About Imugene
View Profile
